Increase in brain tumors is not attributed to mobile phone use
the ONA take:
New research from the University of Auckland found that risk of brain cancer is not increased by mobile phone use. Concerns have been raised about whether use of mobile phones can increase the incidence of brain cancers.
Previous studies from around the world reported findings that showed no risk or a slightly increased risk, with some studies suggesting a substantial risk.
The New Zealand team examined the frequency of brain cancers in total and in subtypes highlighted in other studies, using data from the New Zealand cancer registry.
These investigators found no general increase. They did see, however, was a decrease of approximately 1% per year in people 10 to 69 years. Based on their findings, they report previous findings of large increases in risk are likely to be incorrect.
However, they concede that a study of this type cannot exclude a small risk, or one limited to certain subtypes of cancers, or a risk arising after more than 15 years of phone use.
The research team cannot explain the decrease in brain cancers in New Zealand. An increase in some types of brain cancer among people 70 years and older—in New Zealand and other countries—may be related to improved diagnosis.
Brain cancer is not increased by mobile phone use.
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Impact of Prostate Cancer Diagnosis, Treatment Choice on Quality of Life
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- Refined Equation May Obviate Oncotype DX in Breast Cancer Treatment Decisions
- Risk Factors for Brain Metastases in HER2+ Breast Cancer Identified in Analysis
- Intermediate Oncotype DX Scores Prognostic of OS in Early-stage Breast Cancer
- Colorectal Cancer and Dietary Fiber: Source Is More Important Than Amount
- Reduced Delayed Intensification Impacts Risk of Pediatric ALL Relapse
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|